+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fecal Transplant Therapy Market - Global Forecast 2026-2032- Product Image
Fecal Transplant Therapy Market - Global Forecast 2026-2032- Product Image
Sale

Fecal Transplant Therapy Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090073
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fecal Transplant Therapy Market is projected to reach USD 2.14 Billion in 2026. It is expected to continue growing at a CAGR of 6.72%, reaching USD 3.18 Billion by 2032.

Introduction to Fecal Transplant Therapy

Fecal transplant therapy, also known as fecal microbiota transplantation, transfers processed intestinal microbiota from a screened donor to a recipient. Its clearest established clinical role is treatment of recurrent Clostridioides difficile infection, where restoration of microbial diversity can help interrupt repeated disease cycles. Use in other conditions remains investigational or dependent on local clinical guidance, product standards, and trial evidence.

Clinical and Regulatory Shifts Reshaping Fecal Transplant Therapy

The field is shifting from procedure-based practice toward standardized, quality-controlled microbiota therapeutics. Key changes include tighter donor screening, pathogen testing, traceability, controlled manufacturing, defined administration routes, and greater attention to adverse-event monitoring. Regulatory pathways differ across jurisdictions, creating variation in terminology, eligible indications, informed-consent requirements, and oversight. Evidence generation is also moving toward comparative trials and longer-term follow-up, particularly for immunocompromised patients and uses beyond recurrent infection.

How Artificial Intelligence Is Influencing Fecal Transplant Therapy

Artificial intelligence can support fecal transplant therapy by identifying patient and donor factors associated with treatment response, analyzing microbiome sequencing data, and improving detection of potential contamination or clinically important patterns. It may also assist protocol optimization, adverse-event surveillance, and trial recruitment. However, microbiome datasets are heterogeneous, causal relationships remain difficult to establish, and algorithmic outputs require clinical validation, privacy safeguards, and transparent governance before they influence treatment decisions.

Regional Insights Across Fecal Transplant Therapy

North America has emphasized clinical standardization, regulated microbiota-based products, and evidence from specialist centers. Europe is characterized by national and professional guidance, differing classifications of fecal material, and strong attention to donor safety and data protection. Asia-Pacific combines established hospital expertise with uneven access to testing, manufacturing, and specialist infrastructure. Latin America is developing clinical capacity while facing variation in laboratory resources and regulatory clarity. The Middle East is expanding advanced-care capabilities, with implementation shaped by hospital readiness and local governance. Africa’s progress depends heavily on diagnostic access, specialist training, sustainable screening systems, and context-appropriate delivery models.

Group-Level Perspectives on Fecal Transplant Therapy

Within ASEAN, adoption is likely to reflect differences in infectious-disease burden, tertiary-care capacity, and regulatory maturity. BRICS countries span substantial variation in laboratory infrastructure, public-health priorities, and domestic research capabilities. European Union practice is influenced by cross-border quality, safety, and data requirements while remaining subject to national implementation. G7 systems generally have stronger clinical research and biobanking capabilities, but still differ in reimbursement and regulatory pathways. GCC countries can leverage concentrated tertiary-care networks, although donor programs and specialized manufacturing require local adaptation. NATO members show varied national policies, but collaboration in clinical research, biosafety, and preparedness can support shared standards.

Country Insights Across Priority Fecal Transplant Therapy Markets

Australia and Canada have strong specialist-care and research environments, with access shaped by national clinical governance. Brazil, Mexico, India, China, and Russia reflect large and diverse healthcare systems in which availability can differ considerably between major centers and other regions. France, Germany, Italy, Spain, and the United Kingdom are influenced by European clinical guidance, national regulation, and differing service organization. Japan and South Korea combine advanced hospital infrastructure with distinct approval, reimbursement, and clinical-practice frameworks. In the United States, specialized centers and regulated microbiota-based approaches coexist with ongoing evidence development and detailed safety oversight.

Strategic Priorities for Industry and Clinical Leaders

Leaders should prioritize donor and recipient safety through validated screening, pathogen-control procedures, chain-of-custody systems, and documented follow-up. Building multidisciplinary partnerships among gastroenterology, infectious-disease, microbiology, pharmacy, laboratories, and regulators can improve implementation quality. Organizations should invest in prospective registries, harmonized outcome definitions, microbiome data standards, and transparent reporting of failures and adverse events. For applications beyond recurrent infection, staged evidence generation and carefully governed clinical trials are preferable to premature routine adoption. Training, equitable referral pathways, and contingency planning can help prevent access from being limited to a small number of specialist centers.

Research Methodology for the Fecal Transplant Therapy Assessment

This executive summary uses a structured qualitative synthesis of the supplied market scope and established clinical, regulatory, and technology themes relevant to fecal transplant therapy. The assessment organizes findings by therapy definition, care delivery, safety, evidence development, artificial intelligence, geography, and stakeholder grouping. Regional, group, and country narratives are comparative rather than quantitative and do not imply uniform practice within any jurisdiction. Conclusions should be validated against current peer-reviewed evidence, official regulatory documents, clinical guidelines, and local institutional protocols before operational decisions are made.

Conclusion: Building Safe, Evidence-Based Fecal Transplant Therapy

Fecal transplant therapy is progressing from specialist intervention toward more standardized microbiota-based care, led by the need for reliable safety controls and stronger clinical evidence. Its most defensible role remains treatment of recurrent Clostridioides difficile infection, while broader applications require continued research. Sustainable progress will depend on rigorous manufacturing and screening, responsible data and artificial-intelligence use, coordinated regulation, and equitable access to trained clinical services.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Fecal Transplant Therapy Market, by Type
7.1. Introduction
7.2. Capsule-Based Fecal Microbiota Therapy
7.3. Liquid-Based Fecal Microbiota Therapy
8. Fecal Transplant Therapy Market, by Disease
8.1. Introduction
8.2. Autism Spectrum Disorder
8.3. Clostridium Difficile Infection
8.4. Diabetes Mellitus
8.5. Inflammatory Bowel Disease
8.6. Irritable Bowel Syndrome
8.7. Multiple Sclerosis
8.8. Obesity
9. Fecal Transplant Therapy Market, by Therapy Procedure
9.1. Introduction
9.2. Colonoscopy
9.3. Enema
9.4. Nasogastric (NG) Tube
9.5. Oral Capsules
10. Fecal Transplant Therapy Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Ambulatory Surgical Centers
10.4. Hospitals & Clinics
11. Fecal Transplant Therapy Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Fecal Transplant Therapy Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Fecal Transplant Therapy Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AOBiome Therapeutics, Inc.
15.2. Assembly Biosciences, Inc.
15.3. BiomX Inc.
15.4. Evogene Ltd.
15.5. Ferring Pharmaceuticals
15.6. Finch Therapeutics Group, Inc.
15.7. MaaT Pharma
15.8. Nestlé Health Science
15.9. OpenBiome
15.10. Seres Therapeutics, Inc.
15.11. Taconic Biosciences, Inc.
15.12. Takeda Pharmaceutical Company Limited
15.13. Theriva Biologics, Inc.
15.14. Vedanta Biosciences, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Fecal Transplant Therapy Market, Years Considered for the Study
FIGURE 2. Global Fecal Transplant Therapy Market, Research Design
FIGURE 3. Global Fecal Transplant Therapy Market, Research Framework
FIGURE 4. Global Fecal Transplant Therapy Market, Data Triangulation
FIGURE 5. Global Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Fecal Transplant Therapy Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Fecal Transplant Therapy Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Fecal Transplant Therapy Market Size, by Disease, 2025 vs 2032 (%)
FIGURE 9. Global Fecal Transplant Therapy Market Size, by Disease, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Fecal Transplant Therapy Market Size, by Therapy Procedure, 2025 vs 2032 (%)
FIGURE 11. Global Fecal Transplant Therapy Market Size, by Therapy Procedure, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Fecal Transplant Therapy Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global Fecal Transplant Therapy Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Fecal Transplant Therapy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Fecal Transplant Therapy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Fecal Transplant Therapy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Fecal Transplant Therapy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Fecal Transplant Therapy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Fecal Transplant Therapy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Fecal Transplant Therapy Market Segmentation & Coverage
TABLE 2. Global Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Capsule-Based Fecal Microbiota Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Capsule-Based Fecal Microbiota Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Capsule-Based Fecal Microbiota Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Liquid-Based Fecal Microbiota Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Liquid-Based Fecal Microbiota Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Liquid-Based Fecal Microbiota Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 11. Global Autism Spectrum Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Autism Spectrum Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Autism Spectrum Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Clostridium Difficile Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Clostridium Difficile Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Clostridium Difficile Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Diabetes Mellitus Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Diabetes Mellitus Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Diabetes Mellitus Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Inflammatory Bowel Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Inflammatory Bowel Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Inflammatory Bowel Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Irritable Bowel Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Irritable Bowel Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Irritable Bowel Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Multiple Sclerosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Multiple Sclerosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Multiple Sclerosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Obesity Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Obesity Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Obesity Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 33. Global Colonoscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Colonoscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Colonoscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Enema Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Enema Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Enema Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Nasogastric (NG) Tube Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Nasogastric (NG) Tube Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Nasogastric (NG) Tube Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Oral Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Oral Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Oral Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 46. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Fecal Transplant Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Fecal Transplant Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 61. North America Fecal Transplant Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. North America Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 63. North America Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 64. North America Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 65. North America Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 66. Latin America Fecal Transplant Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Latin America Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 68. Latin America Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 69. Latin America Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 70. Latin America Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 71. Europe Fecal Transplant Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Europe Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 73. Europe Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 74. Europe Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 75. Europe Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 76. Middle East Fecal Transplant Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Middle East Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 78. Middle East Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 79. Middle East Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 80. Middle East Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 81. Africa Fecal Transplant Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Africa Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 83. Africa Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 84. Africa Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 85. Africa Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 86. Global Fecal Transplant Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. ASEAN Fecal Transplant Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. ASEAN Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 89. ASEAN Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 90. ASEAN Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 91. ASEAN Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 92. GCC Fecal Transplant Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. GCC Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 94. GCC Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 95. GCC Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 96. GCC Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 97. European Union Fecal Transplant Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. European Union Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 99. European Union Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 100. European Union Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 101. European Union Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 102. BRICS Fecal Transplant Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. BRICS Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 104. BRICS Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 105. BRICS Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 106. BRICS Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 107. G7 Fecal Transplant Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. G7 Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 109. G7 Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 110. G7 Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 111. G7 Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 112. NATO Fecal Transplant Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. NATO Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 114. NATO Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 115. NATO Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 116. NATO Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 117. Global Fecal Transplant Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. United States Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 119. United States Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 120. United States Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 121. United States Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 122. United States Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 123. Canada Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 124. Canada Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 125. Canada Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 126. Canada Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 127. Canada Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 128. Mexico Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 129. Mexico Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 130. Mexico Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 131. Mexico Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 132. Mexico Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 133. Brazil Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 134. Brazil Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 135. Brazil Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 136. Brazil Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 137. Brazil Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 138. United Kingdom Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 139. United Kingdom Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 140. United Kingdom Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 141. United Kingdom Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 142. United Kingdom Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 143. Germany Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 144. Germany Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 145. Germany Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 146. Germany Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 147. Germany Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 148. France Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 149. France Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 150. France Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 151. France Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 152. France Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 153. Russia Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 154. Russia Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 155. Russia Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 156. Russia Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 157. Russia Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 158. Italy Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 159. Italy Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 160. Italy Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 161. Italy Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 162. Italy Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 163. Spain Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 164. Spain Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 165. Spain Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 166. Spain Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 167. Spain Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 168. China Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 169. China Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 170. China Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 171. China Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 172. China Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 173. India Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 174. India Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 175. India Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 176. India Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 177. India Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 178. Japan Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 179. Japan Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 180. Japan Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 181. Japan Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 182. Japan Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 183. Australia Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 184. Australia Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 185. Australia Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 186. Australia Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 187. Australia Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 188. South Korea Fecal Transplant Therapy Market Size, 2017-2032 (USD Million)
TABLE 189. South Korea Fecal Transplant Therapy Market Size, by Type, 2017-2032 (USD Million)
TABLE 190. South Korea Fecal Transplant Therapy Market Size, by Disease, 2017-2032 (USD Million)
TABLE 191. South Korea Fecal Transplant Therapy Market Size, by Therapy Procedure, 2017-2032 (USD Million)
TABLE 192. South Korea Fecal Transplant Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 193. Global Fecal Transplant Therapy Market Share, by Key Player, 2025
TABLE 194. Global Fecal Transplant Therapy Market, Key Experts

Companies Mentioned

  • AOBiome Therapeutics, Inc.
  • Assembly Biosciences, Inc.
  • BiomX Inc.
  • Evogene Ltd.
  • Ferring Pharmaceuticals
  • Finch Therapeutics Group, Inc.
  • MaaT Pharma
  • Nestlé Health Science
  • OpenBiome
  • Seres Therapeutics, Inc.
  • Taconic Biosciences, Inc.
  • Takeda Pharmaceutical Company Limited
  • Theriva Biologics, Inc.
  • Vedanta Biosciences, Inc.

Related Topics

Related Reports

Pharmaceuticals - Enterprise ICT - Product Image

Pharmaceuticals - Enterprise ICT

  • Report
  • 54 Pages
  • Global
From
U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F - Product Image

U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F

  • Report
  • 85 Pages
  • United States
From
Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028 - Product Image

Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028

  • Report
  • 286 Pages
  • North America
From
Pharmaceutical Glycerine Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Glycerine Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Fecal Transplant Therapy Market Report 2026 - Product Image

Fecal Transplant Therapy Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.